Immunohistochemical staining of phosphorylated-ERK in post-chemotherapeutic samples is a potential predictor of the prognosis of neuroblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunohistochemical staining of phosphorylated-ERK in post-chemotherapeutic samples is a potential predictor of the prognosis of neuroblastoma

Published:2021-01-04 Issue:2 Volume:37 Page:287-291
ISSN:0179-0358
Container-title:Pediatric Surgery International
language:en
Short-container-title:Pediatr Surg Int

Author:

Tanaka Tomoko,Togashi Yuichi,Takeuchi Yuki,Higashi Mayumi,Fumino Shigehisa,Tajiri Tatsuro

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Surgery,Pediatrics, Perinatology and Child Health

Link

http://link.springer.com/content/pdf/10.1007/s00383-020-04806-w.pdf

Reference13 articles.

1. Matthay KK, Maris JM, Schleiermacher G, Nakagawara A, Mackall CL, Diller L, Weiss WA (2016) Neuroblastoma Nat Rev Dis Primers 2:16078. https://doi.org/10.1038/nrdp.2016.78

2. Greengard EG (2018) Molecularly targeted therapy for neuroblastoma. Children (Basel). https://doi.org/10.3390/children5100142

3. Cañete A (2020) High-risk neuroblastoma: where do we go? Ann Oncol 31(3):326–327. https://doi.org/10.1016/j.annonc.2019.12.003

4. Eleveld TF, Oldridge DA, Bernard V, Koster J, Daage LC, Diskin SJ, Schild L, Bentahar NB, Bellini A, Chicard M, Lapouble E, Combaret V, Legoix-Ne P, Michon J, Pugh TJ, Hart LS, Rader J, Attiyeh EF, Wei JS, Zhang S, Naranjo A, Gastier-Foster JM, Hogarty MD, Asgharzadeh S, Smith MA, Guidry Auvil JM, Watkins TB, Zwijnenburg DA, Ebus ME, van Sluis P, Hakkert A, van Wezel E, van der Schoot CE, Westerhout EM, Schulte JH, Tytgat GA, Dolman ME, Janoueix-Lerosey I, Gerhard DS, Caron HN, Delattre O, Khan J, Versteeg R, Schleiermacher G, Molenaar JJ, Maris JM (2015) Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations. Nat Genet 47(8):864–871. https://doi.org/10.1038/ng.3333

5. Tanaka T, Higashi M, Kimura K, Wakao J, Fumino S, Iehara T, Hosoi H, Sakai T, Tajiri T (2016) MEK inhibitors as a novel therapy for neuroblastoma: their in vitro effects and predicting their efficacy. J Pediatr Surg 51(12):2074–2079. https://doi.org/10.1016/j.jpedsurg.2016.09.043

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The synergistic antitumor effect of combination therapy with a MEK inhibitor and YAP inhibitor on pERK-positive neuroblastoma;Biochemical and Biophysical Research Communications;2021-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3